Clinical Trials Logo
  1. Home
  2. Crohn's Disease (CD)
  3. NCT04089514

A Real-world Study of Imraldi® Use — PROPER  

Crohn's Disease (CD) Clinical Trial

Official title:
Pan-EU Real-World Experience With Imraldi®

Clinical Trial Summary

The primary objective of this study is to evaluate candidate predictors of persistence on adalimumab (Imraldi®) participants diagnosed with immune-mediated inflammatory disease in Europe (EU). The secondary objectives of this study are to describe participant clinical characteristics at baseline, utilization of Imraldi® over time, biologic drug effectiveness over time, participant satisfaction with biologic administration, routine laboratory values and clinical evaluation measurements over time, use of relevant concomitant medication use over time, immunogenicity of biosimilars and to summarize safety events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04089514
Study type Observational
Source Biogen
Contact
Status Completed
Phase
Start date June 30, 2019
Completion date November 30, 2021
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04524611 - Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) Phase 3
Completed NCT02778464 - Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
Terminated NCT02775656 - UCB Cimzia Pregnancy Follow-up Study
Active, not recruiting NCT02782663 - A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease Phase 2
Completed NCT02108821 - Fecal Microbiota Transplantation in Pediatric Patients Phase 1
Completed NCT01364896 - Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Completed NCT04271748 - The Impact of Time Restricted Feeding in Crohn's Disease N/A
Completed NCT03801928 - Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
Recruiting NCT04779320 - A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Phase 3
Completed NCT01877577 - Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D N/A